openPR Logo
Press release

Biosimilars Market Estimated to Experience a Hike in Growth by 2024

11-29-2017 06:33 AM CET | Health & Medicine

Press release from: Transparency Market Research

Biosimilars Market Estimated to Experience a Hike in Growth

Global Biosimilars Market: Overview

The global market for biosimilars is projected to grow at a significant rate in the coming few years, owing to the low cost of these products. With the growing focus on research and development activities, the market is expected to generate promising opportunities in the next few years.

The research study offers a thorough overview of the global biosimilars market, providing understanding into the major factors that are projected to affect the development of the market in the next few years. The segmentation of the global biosimilars market with the help of analytical tools helps the readers and market players in attaining a strong understanding of the overall market. Furthermore, the growth drivers, restraints, current trends, opportunities, and the limitations in the market have been discussed in the research report.

Request to View TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=100

Global Biosimilars Market: Drivers and Barriers

The emergence of off-patent biologic products is one of the major factors anticipated to encourage the growth of the global biosimilars market in the next few years. These drugs are comparatively cost-effective, owing to which the demand is expected to increase substantially in the next few years. In addition, the growing prevalence of different ailments across the globe is predicted to fuel the growth of the market.

On the other hand, the innovative strategies that have been devised by biologic drug manufacturers are estimated to curb the development of the global biosimilars market, especially the new entrants of the market. Furthermore, the global biosimilars market is expected to witness several challenges throughout the forecast period. The need for a complex infrastructure for the production of biosimilars and the lengthy clinical trials required to attain the approval from the regulatory bodies are some of the important factors likely to restrict the growth of the global market in the next few years.

Global Biosimilars Market: Regional Outlook

From a geographical viewpoint, Europe is expected to lead the global biosimilars market and account for a large share in the next few years. The high growth of this region can be attributed to the presence of several biosimilar drugs including, binocrits, tevagrastim, and omnitrope. In addition, the strict regulatory framework and the rising products in the pipeline are estimated to contribute substantially towards the development of the Europe biosimilars market in the next few years.

Furthermore, the promising opportunities for the key players in the developing economies are estimated to encourage the growth of the biosimilars market in Asia Pacific in the next few years. As per the research study, this region is expected to register a progressive growth rate in the near future. On the other hand, the stringent government regulations in the U.S. are projected to restrict the growth of the North America market.

Request for Broucher @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=100

Companies Mentioned in the Research Report

Some of the leading players operating in the biosimilars market across the globe are Genentech, Ranbaxy Laboratories, Sandoz, Bristol-Myers Squibb, Cipla, Abbott, and Astra Zeneca. The growing focus of technological developments in the global market and the notable efforts taken by the leading players are some of the factors likely to supplement the growth of the global market in the next few years. The increasing level of competition owing to the growing participation of players is predicted to encourage the market growth in the coming years.

ABOUT US:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

CONTACT:
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market Estimated to Experience a Hike in Growth by 2024 here

News-ID: 836254 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for Biosimilars

Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Biosimilars Market Size During the Forecast Period? The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth? The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million